Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
The landscape of pharmaceutical research is constantly evolving, driven by the need for more effective and targeted therapies. Among the various heterocyclic scaffolds that have garnered significant attention, pyrrolopyrimidine derivatives stand out due to their diverse biological activities. These compounds form the core structure of many groundbreaking drugs, particularly those targeting specific enzymatic pathways like Janus kinase (JAK) inhibition. NINGBO INNO PHARMCHEM CO.,LTD. plays a crucial role in this domain by supplying high-quality intermediates essential for synthesizing these complex molecules.
One such vital intermediate is N-Methyl-N-[(3R,4R)-4-Methyl-1-(phenylmethyl)-3-piperidinyl]-7H-Pyrrolo[2,3-d]pyrimidin-4-amine, identified by CAS number 477600-73-0. This compound is a critical building block in the synthesis of Tofacitinib, a well-known JAK inhibitor used to treat autoimmune diseases. The demand for reliable and high-purity CAS 477600-73-0 pharmaceutical raw material is paramount for manufacturers aiming to produce Tofacitinib and similar therapeutic agents with consistent quality. NINGBO INNO PHARMCHEM CO.,LTD. ensures that the N-methyl-N-[(3R,4r)-4-methylpiperidin-3-yl]-7h-pyrrolo[2,3-d]pyrimidin-4-amine bulk purchase is straightforward and efficient, supporting large-scale production needs.
The synthesis of JAK inhibitors requires precise stereochemistry and high chemical purity to ensure efficacy and minimize side effects. The availability of a dependable N-Methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-7H-Pyrrolo[2,3-d]pyrimidin-4-amine hydrochloride supplier is therefore indispensable for pharmaceutical companies. By providing intermediates like this, NINGBO INNO PHARMCHEM CO.,LTD. contributes directly to the advancement of treatments for conditions such as rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. Understanding the Tofacitinib intermediate price is also crucial for cost-effective drug development, and NINGBO INNO PHARMCHEM CO.,LTD. strives to offer competitive pricing without compromising on quality.
The ongoing research into new pyrrolopyrimidine-based drugs highlights the continued importance of these chemical scaffolds. As drug discovery efforts expand, the demand for specialized intermediates like N-Methyl-N-[(3R,4R)-4-Methyl-1-(phenylmethyl)-3-piperidinyl]-7H-Pyrrolo[2,3-d]pyrimidin-4-amine will only grow. NINGBO INNO PHARMCHEM CO.,LTD. remains committed to supporting the pharmaceutical industry by providing these essential chemical components, thereby accelerating the journey from laboratory research to life-changing medicines.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
